Published in Agents Actions on February 01, 1983
Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera. Dig Dis Sci (1982) 2.14
Sialic acid content and proteolytic activity in gastric juice in humans. An approach for appreciating mucus glycoprotein erosion. Dig Dis Sci (1988) 2.06
[The automatic determination of proteolytic activity of gastric juice]. Biol Gastroenterol (Paris) (1968) 1.60
[How to express results of 24-hour gastric pH measurement? Choice of a mode of expression in 27 healthy subjects]. Gastroenterol Clin Biol (1989) 1.51
Duodenogastric reflux in children: measurement of phospholipids and trypsin in gastric content. J Pediatr Gastroenterol Nutr (1990) 1.44
Results of surgical management in 92 consecutive patients with Zollinger-Ellison syndrome. Ann Surg (1981) 1.27
Cimetidine treatment of acute and chronic Zollinger-Ellison syndrome. World J Surg (1979) 1.11
Current approach to the management of tumoral process in patients with gastrinoma. World J Surg (1986) 1.09
Diagnosis and treatment of Zollinger-Ellison syndrome. Baillieres Clin Gastroenterol (1988) 1.07
Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome. Gut (1992) 1.03
Evaluation of antisecretory drug therapy of Zollinger-Ellison syndrome (ZES) using 24-hour pH monitoring. Dig Dis Sci (1983) 1.02
Effect of somatostatin on normal and gastric-stimulated cell proliferation in the gastric and intestinal mucosae of the rat. Digestion (1979) 0.97
Delayed gastric emptying in anorexia nervosa is improved by completion of a renutrition program. Dig Dis Sci (1988) 0.97
Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia. Pancreas (1993) 0.97
Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment. Gastroenterology (1989) 0.97
Gastric HCO3-stimulated ATPase: evidence against its microsomal localization in rat fundus mucosa. Biochim Biophys Acta (1974) 0.96
C1-transport in gastric micorsomes. An ATP-dependent influx sensitive to membrane potential and to protein kinase inhibitor. J Biol Chem (1980) 0.95
A historian looks at the professions in America. J Am Coll Dent (1966) 0.95
Determination of histamine, methylhistamines and histamine-o-phthaldialdehyde complexes by two high-performance liquid chromatographic procedures. Application to biological samples. J Chromatogr (1983) 0.93
Haemodynamic effects of remifentanil in children with and without intravenous atropine. An echocardiographic study. Br J Anaesth (2004) 0.93
Acute spontaneously recovering ulcerating colitis (ARUC). Report of 6 cases. Am J Dig Dis (1977) 0.93
[Efficacy of ranitidine and cimetidine in the treatment of gastric or duodenal ulcer resistant to an initial treatment with cimetidine. Multicenter controlled therapeutic trial]. Gastroenterol Clin Biol (1985) 0.92
Parietal and chief cell populations in four cases of the Zollinger-Ellison syndrome. Gastroenterology (1972) 0.91
Development of gastric argyrophil carcinoid tumors in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long-term antisecretory treatment. Cancer (1987) 0.91
Depolymerization of solubilized gastric (H+ + K+)-ATPase by n-octylglucoside or cholate. Biochim Biophys Acta (1986) 0.89
Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment. Dig Dis Sci (1993) 0.88
Effect of the histamine-1 antagonist astemizole alone or with omeprazole on rat gastric mucosa. Scand J Gastroenterol (1991) 0.88
Carrageenan: effects in animals. Lancet (1970) 0.87
Ranitidine upon meal-induced gastric secretion: oral pharmacokinetics and plasma concentration effect relationships. Br J Clin Pharmacol (1982) 0.87
Inhibitory effect of prolonged administration of long-acting somatostatin on gastrin-stimulated fundic epithelial cell growth in the rat. Digestion (1982) 0.87
[Histological and cytological study of the tumoral and nontumoral endocrine pancreas in the Zollinger-Ellison syndrome]. Rev Int Hepatol (1966) 0.87
Significance and regulation of gastric secretion of platelet-activating factor (PAF-acether) in man. Dig Dis Sci (1992) 0.85
New somatostatin molecule for management of endocrine tumours. Gut (1985) 0.85
Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia type I. World J Surg (1993) 0.85
A quality of life study in five hundred and eighty-one duodenal ulcer patients. Maintenance versus intermittent treatment with nizatidine. Scand J Gastroenterol Suppl (1994) 0.85
BI-RADS categorisation of 2,708 consecutive nonpalpable breast lesions in patients referred to a dedicated breast care unit. Eur Radiol (2011) 0.84
[An approach to automatic determination of the proteolytic activity of gastric juice under conditions of initial reaction rate]. Biol Gastroenterol (Paris) (1975) 0.84
Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients. Acta Oncol (1993) 0.84
Carrageenan and the human gut. Lancet (1970) 0.84
Ranitidine and cimetidine in Zollinger-Ellison syndrome. Br J Clin Pharmacol (1980) 0.84
Management of Zollinger-Ellison syndrome. N Engl J Med (1980) 0.84
Interest of a combined antisecretory treatment, cimetidine and pirenzepin, in the management of severe forms of Zollinger-Ellison syndrome. Digestion (1980) 0.83
Gynecomastia and histamine-2 antagonists. Lancet (1982) 0.83
[Letter: Inhibitor of H 2 histamine receptors and the Zollinger-Ellison syndrome]. Nouv Presse Med (1974) 0.83
Gastric proton pump is expressed in the inner ear and choroid plexus of the rat. Hear Res (2000) 0.83
A 'quality of life questionnaire' adapted to duodenal ulcer therapeutic trials. Scand J Gastroenterol Suppl (1994) 0.82
Interaction between the N-terminal domain of gastric H,K-ATPase and the spectrin binding domain of ankyrin III. J Biol Chem (2000) 0.82
[Initial results with caerulein in pancreatic function tests in man]. Acta Gastroenterol Belg (1971) 0.82
[Isolation and purification of a histamine-like gastrosecretagogue from gastric antral mucosa]. Gastroenterol Clin Biol (1982) 0.82
Comparative effects of antrocolic transposition and antrectomy on fundic mucosa and acid secretion of the rat. Gastroenterology (1973) 0.81
Long-term treatment with octreotide in patients with the Zollinger-Ellison syndrome. Eur J Clin Invest (1993) 0.81
Gastric secretion of platelet activating factor and precursors in healthy humans: effect of pentagastrin. Gut (1993) 0.81
Parietal cell vagotomy in dogs. A comparative study of the effects on gastric secretion and antral muscle contraction. Digestion (1978) 0.81
[Effect of a gastrin agonist isolated from antral mucosa on gastric secretion (author's transl)]. J Physiol (Paris) (1980) 0.81
[Efficacy of combined anti-secretory treatment (cimétidine and pirenzepin) in Zollinger-Ellison syndrome]. Nouv Presse Med (1977) 0.81
Interaction of 3H-labelled synthetic human gastrin I with rat gastric plasma membranes. Evidence for the existence of biologically reactive gastrin receptor sites. FEBS Lett (1976) 0.81
[Rat bioassay with urine (PSU) for diagnosis and postoperative follow-up in Zollinger-Ellison syndrome (author's transl)]. Acta Gastroenterol Belg (1973) 0.81
[The observance of Ramadan and its repercussion on gastric secretion]. Gastroenterol Clin Biol (1994) 0.81
A comparative evaluation of secretin bolus and secretin infusion as secretin provocation tests in the Zollinger-Ellison syndrome. Scand J Gastroenterol (1985) 0.81
Antisecretory and anti-ulcer effects of morphine in rats after gastric mucosal aggression. Eur J Pharmacol (1991) 0.80
Gastric acid secretion results from antagonistic effects of antral histamine (Antramine) and somatostatin on gastrin. Agents Actions (1984) 0.80
[Therapeutic value of somatostatin in gastroenterology. Theoretical basis. Practical trends]. Gastroenterol Clin Biol (1980) 0.80
Rebound effect after somatostatin treatment in Verner-Morrison syndrome. Lancet (1979) 0.80
Antramine (antral histamine) antagonizes somatostatin inhibition on endogenous gastrin-induced gastric secretion. A new hypothesis for the role of histamine in gastric secretion regulation. Scand J Gastroenterol (1985) 0.80
Gastric microsomal NADH-cytochrome b5 reductase: characterization and solubilization. Comp Biochem Physiol B (1985) 0.80
The gastric antisecretory activity of a phenothiazine molecule, LM 24056. Arzneimittelforschung (1982) 0.80
Prolonged treatment of Zollinger-Ellison syndrome by long-acting somatostatin. Lancet (1986) 0.80
Intragastric pH profile during acute respiratory failure in patients with chronic obstructive pulmonary disease. Effect of ranitidine and enteral feeding. Chest (1986) 0.80
Action of somatostatin analogue (SMS 201-995) on the growth-promoting effect resulting from sustained achlorhydria in rat gastric mucosa, with special reference to endocrine cell behaviour. Eur J Clin Invest (1988) 0.80
Effect of different forms of methionine on lactational performance of dairy cows. J Dairy Sci (2006) 0.79
Improving intestinal amino acid supply of pre- and postpartum dairy cows with rumen-protected methionine and lysine. J Dairy Sci (2005) 0.79
Antral gastrin- and somatostatin-producing cells and intraluminal peptide secretion in normal subjects and duodenal ulcer patients with and without vagotomy. Regul Pept (1986) 0.79
[A model for assessment of gastric antisecretory power: application to proglumide (author's transl)]. Gastroenterol Clin Biol (1977) 0.79
[Diagnostic significance of the secretin provocation test in Zollinger-Ellison syndrome. Analysis of 21 consecutive positive secretin test (author's transl)]. Gastroenterol Clin Biol (1977) 0.79
[Inhibition of gastric secretion by subcutaneous administration of cyclic somatostatin in man (author's transl)]. Gastroenterol Clin Biol (1981) 0.79
A monoclonal antibody which inhibits H+/K(+)-ATPase activity but not chloride conductance. Biochim Biophys Acta (1989) 0.79
N,N-dimethyl-10-(3-quinuclidinyl)-2-phenothiazine sulfonamide (LM 24056): mode of action of its gastric antisecretory effect. Arzneimittelforschung (1983) 0.79
[Actions of a gastrin agonist isolated from antral mucosa: histamine-like effects; comparison with histamine (author's transl)]. J Physiol (Paris) (1981) 0.78
Efficient solubilization and purification of the gastric H+, K+-ATPase for functional and structural studies. Biochem J (2000) 0.78
[Idiopathic ulcerative proctitis. Clinical presentation and endoscopic outcome]. Gastroenterol Clin Biol (1991) 0.78